checkAd

     127  0 Kommentare Veeva Development Cloud Streamlining Drug Development Industrywide

    Unified application suites for clinical, regulatory, quality, and safety eliminate siloes to increase efficiency and improve compliance

    BARCELONA, Spain, May 19, 2021 /PRNewswire/ -- A growing number of life sciences companies are adopting Veeva Development Cloud applications from Veeva Systems (NYSE: VEEV) in an industrywide shift to streamline drug development. More than 650 companies use Veeva Development Cloud applications today, and more than 250 are leveraging multiple Veeva Vault applications across functional areas to enable and connect drug development and manufacturing teams.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Veeva Systems A!
    Long
    180,66€
    Basispreis
    1,61
    Ask
    × 10,22
    Hebel
    Short
    217,70€
    Basispreis
    1,99
    Ask
    × 7,94
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Veeva Systems

    Veeva Development Cloud brings together suites of unified applications for clinical, regulatory, quality, and safety on a single cloud platform, eliminating organizational siloes. More than 350 companies are accelerating trial execution with Vault Clinical applications, more than 250 are streamlining regulatory processes with Vault RIM, more than 350 are unifying quality management with Vault Quality, and more than 35 are improving pharmacovigilance with Vault Safety.

    Vault Connections in Veeva Development Cloud drive cross-functional business processes across the product lifecycle. For example, Connections enable companies to bring together clinical operations and regulatory for faster submissions; quality and regulatory for simplified change control and variation management; and clinical data and operations for real-time visibility into patient enrollment.

    "We're dedicated to bringing innovations to market that help the industry accelerate drug development," said Rik Van Mol, senior vice president of Veeva Development Cloud. "Veeva Development Cloud is enabling customers to improve collaboration across teams and speed the delivery of treatments to patients."

    What customers are saying about Veeva Development Cloud:

    "Managing drug development across multiple siloed systems is no longer sustainable to move with speed and efficiency," said Klaas Boone, senior director, business information systems at argenx. "We're passionate about making what we do better, and using Veeva Development Cloud applications to connect our teams will help drive innovation from clinical trial through regulatory submission and manufacturing." 

    Seite 1 von 2



    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    Veeva Development Cloud Streamlining Drug Development Industrywide Unified application suites for clinical, regulatory, quality, and safety eliminate siloes to increase efficiency and improve compliance BARCELONA, Spain, May 19, 2021 /PRNewswire/ - A growing number of life sciences companies are adopting Veeva …